L-Cycloserine

CAS No. 339-72-0

L-Cycloserine( (-)-Cycloserine | (S)-Cycloserine | L-4-amino 3-Isoxazolidinone | Levcycloserine )

Catalog No. M14151 CAS No. 339-72-0

L-cycloserine irreversibly inhibit GABA pyridoxal 5′-phosphate-dependent aminitransferase in E. coli.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 27 In Stock
10MG 41 In Stock
25MG 54 In Stock
50MG 60 In Stock
100MG 87 In Stock
200MG 129 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Cycloserine
  • Note
    Research use only, not for human use.
  • Brief Description
    L-cycloserine irreversibly inhibit GABA pyridoxal 5′-phosphate-dependent aminitransferase in E. coli.
  • Description
    L-cycloserine irreversibly inhibit GABA pyridoxal 5′-phosphate-dependent aminitransferase in E. coli, as well in the brains of various animals in a time-dependent manner, results in increased levels of gamma-aminobutyric acid (GABA), which is an inhibitory neurotransmitter in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Cycloserine | (S)-Cycloserine | L-4-amino 3-Isoxazolidinone | Levcycloserine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    339-72-0
  • Formula Weight
    102.09
  • Molecular Formula
    C3H6N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C1NOCC1N
  • Chemical Name
    4-aminoisoxazolidin-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Noda M, et al. J Biol Chem. 2004 Oct 29;279(44):46143-52.
molnova catalog
related products
  • RH01386

    RH01386 is a small molecule that can prevent ER stress-induced β cell dysfunction and death, and inhibits proapoptotic gene expression,has the potential for type 2 diabetes treatment. RH01386 restores ER stress-impaired glucose-stimulated insulin secretion responses.

  • HS271

    HS271 is a highly potent, orally active and selective IRAK4 inhibitor, with an IC50 of 7.2 μM. HS271 exhibits superior enzymatic and cellular activities, as well as excellent pharmacokinetic properties.

  • SR8278

    SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.